BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7508445)

  • 1. Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors.
    Yonezawa K; Ando A; Kaburagi Y; Yamamoto-Honda R; Kitamura T; Hara K; Nakafuku M; Okabayashi Y; Kadowaki T; Kaziro Y
    J Biol Chem; 1994 Feb; 269(6):4634-40. PubMed ID: 7508445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
    Noguchi T; Matozaki T; Horita K; Fujioka Y; Kasuga M
    Mol Cell Biol; 1994 Oct; 14(10):6674-82. PubMed ID: 7935386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
    Harada S; Smith RM; Smith JA; White MF; Jarett L
    J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.
    Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY
    Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects.
    Krook A; Whitehead JP; Dobson SP; Griffiths MR; Ouwens M; Baker C; Hayward AC; Sen SK; Maassen JA; Siddle K; Tavaré JM; O'Rahilly S
    J Biol Chem; 1997 Nov; 272(48):30208-14. PubMed ID: 9374504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc.
    Kaburagi Y; Yamamoto-Honda R; Tobe K; Ueki K; Yachi M; Akanuma Y; Stephens RM; Kaplan D; Yazaki Y; Kadowaki T
    Endocrinology; 1995 Aug; 136(8):3437-43. PubMed ID: 7543044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
    Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
    J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation.
    Ouwens DM; van der Zon GC; Pronk GJ; Bos JL; Möller W; Cheatham B; Kahn CR; Maassen JA
    J Biol Chem; 1994 Dec; 269(52):33116-22. PubMed ID: 7806540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action.
    Krook A; Moller DE; Dib K; O'Rahilly S
    J Biol Chem; 1996 Mar; 271(12):7134-40. PubMed ID: 8636149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin stimulates association of insulin receptor substrate-1 with the protein abundant Src homology/growth factor receptor-bound protein 2.
    Tobe K; Matuoka K; Tamemoto H; Ueki K; Kaburagi Y; Asai S; Noguchi T; Matsuda M; Tanaka S; Hattori S
    J Biol Chem; 1993 May; 268(15):11167-71. PubMed ID: 8388384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dominant-negative mutant of mSOS1 inhibits insulin-induced Ras activation and reveals Ras-dependent and -independent insulin signaling pathways.
    Sakaue M; Bowtell D; Kasuga M
    Mol Cell Biol; 1995 Jan; 15(1):379-88. PubMed ID: 7799946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of IRS-1 in insulin signal transmission.
    Sun XJ; Miralpeix M; Myers MG; Glasheen EM; Backer JM; Kahn CR; White MF
    J Biol Chem; 1992 Nov; 267(31):22662-72. PubMed ID: 1385403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway.
    Chow JC; Condorelli G; Smith RJ
    J Biol Chem; 1998 Feb; 273(8):4672-80. PubMed ID: 9468528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.
    Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM
    J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells.
    Niessen M; Jaschinski F; Item F; McNamara MP; Spinas GA; Trüb T
    Exp Cell Res; 2007 Feb; 313(4):805-15. PubMed ID: 17222824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IRS-1-GRB-2 complexes in insulin signaling.
    Myers MG; Wang LM; Sun XJ; Zhang Y; Yenush L; Schlessinger J; Pierce JH; White MF
    Mol Cell Biol; 1994 Jun; 14(6):3577-87. PubMed ID: 8196603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein.
    Kovacina KS; Roth RA
    Biochem Biophys Res Commun; 1993 May; 192(3):1303-11. PubMed ID: 7685165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
    Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
    J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.